Xymera Bioscience Private Limited

Xymera Bioscience Private Limited - pharma in Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U85100DL2016PTC308653 Incorporated 28 November 2016 ROC Delhi HQ Delhi, Delhi, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹3.71 Cr
▲ 47.00% YoY
EBITDA · FY 2024
Locked
In full report
Net profit · FY 2024
Locked
In full report
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Open charges
₹30 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Last financials
Mar 2025
Balance sheet date

About Xymera Bioscience Private Limited

Data last updated:

Xymera Bioscience Private Limited is a private limited company based in Delhi, Delhi, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 28 November 2016, the company has been in operation for over 10 years.

Registered with ROC Delhi under CIN U85100DL2016PTC308653.

Capital: an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. Formerly known as Xymera Bioscience (Opc) Private Limited. It is led by directors Pradeep Manral and Ramashish Kukreti.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Office No – 223, Manglam Paradise Plot No 8 Sector 3 Rohini, Delhi, Delhi, India – 110085.

As per the financials filed for FY 2024, the company reported a revenue of ₹3.71 Cr, a growth of 47% compared to the previous year.

As per MCA filings, the company has open charges of ₹30 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website xymerabioscience.com.

Company Details of Xymera Bioscience Private Limited
CIN U85100DL2016PTC308653
Registration Number 308653
Incorporation Date 28 November 2016
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    Office No – 223, Manglam Paradise Plot No 8 Sector 3 Rohini, Delhi, Delhi, India – 110085
  • Industry
    Pharma, Drug Formulation & Development
Company report
Xymera Bioscience Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Xymera Bioscience Private Limited report

Financials, compliance, directors, charges, ownership and filings for Xymera Bioscience Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Xymera Bioscience

Xymera Bioscience has one previous CIN (Corporate Identification Number): U85100DL2016OPC308653. The current CIN is U85100DL2016PTC308653, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U85100DL2016PTC308653Current
U85100DL2016OPC308653Previous

Business Activity of Xymera Bioscience

The main business activity of Xymera Bioscience is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparationsLocked
Premium access

Business activity turnover details for Xymera Bioscience Private Limited

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Xymera Bioscience

Xymera Bioscience Private Limited is audited by GROVER LUTHRA AND CHHABBRA for the financial year 2023.

NameStatusAppointment DateCessation Date
GROVER LUTHRA AND CHHABBRALockedLockedLocked
Premium access

Complete auditor history for Xymera Bioscience Private Limited

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Xymera Bioscience Private Limited

Xymera Bioscience has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Pradeep ManralDirector13 Aug 20224 Years 1 MonthsCurrent
Ramashish KukretiDirector13 Aug 20224 Years 1 MonthsCurrent

Financials of Xymera Bioscience Private Limited FY 2025 filings available

Xymera Bioscience Private Limited reported revenue of ₹3.71 Cr (up 47.00% YoY) for FY 2024.

Revenue · FY 2024
₹3.71 Cr ▲ 47.00%
Premium access

Ten-year financial statements for Xymera Bioscience Private Limited

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Xymera Bioscience

Premium access

Shareholding and ownership data for Xymera Bioscience Private Limited

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Xymera Bioscience

Open charges
₹30 Lakh
Satisfied charges
₹0
Breakdown by lending institutions
Hdfc Bank Limited₹0.30 Cr
Latest charge details
DateLenderAmountStatus
30 Aug 2024Hdfc Bank Limited₹30 LakhOpen

Total charge records: 1 View all charges

Employees and EPFO Compliance at Xymera Bioscience

Employment history and EPFO contributions of people linked to Xymera Bioscience.

Premium access

Employee and EPFO history for Xymera Bioscience Private Limited

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Xymera Bioscience

Premium access

GST registrations and filing compliance for Xymera Bioscience Private Limited

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Xymera Bioscience

Premium access

Credit ratings, litigation, and regulatory alerts for Xymera Bioscience Private Limited

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Xymera Bioscience

Premium access

MSME payment history for Xymera Bioscience Private Limited

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Xymera Bioscience

Premium access

Corporate group structure for Xymera Bioscience Private Limited

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Xymera Bioscience

Premium access

MCA filings and documents for Xymera Bioscience Private Limited

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Xymera Bioscience

Activity
30 Sep 2025
Xymera Bioscience Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Xymera Bioscience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
30 Aug 2024
A charge with Hdfc Bank Limited amounted to Rs. 30.00 Lakh with Charge ID 100999395 was registered on 30 Aug 2024.
Directors
13 Aug 2022
Pradeep Manral was appointed as a Director on 13 Aug 2022 & has been associated with this company since 4 years 1 month.
Directors
13 Aug 2022
Ramashish Kukreti was appointed as a Director on 13 Aug 2022 & has been associated with this company since 4 years 1 month.
Activity
28 Nov 2016
Xymera Bioscience Private Limited was registered on 28 Nov 2016 with Roc Delhi & aged 9 years 10 months as per MCA records.

Frequently Asked Questions about Xymera Bioscience Private Limited

Xymera Bioscience is an active private limited company in the pharma sector based in Delhi, Delhi, India. It was incorporated on 28 November 2016 (10+ years old) and is registered under CIN U85100DL2016PTC308653.

Xymera Bioscience reported revenue of ₹3.71 Cr for FY 2024 (up 47.00% YoY).

The current directors of Xymera Bioscience are:

The primary industry of Xymera Bioscience is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Xymera Bioscience can be reached at the registered office: Office No – 223, Manglam Paradise Plot No 8 Sector 3 Rohini, Delhi, Delhi, India – 110085, or through the website xymerabioscience.com.

The authorised capital is ₹2 Lakh, and the paid-up capital is ₹2 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available